Syndax Pharmaceuticals Inc

NASDAQ:SNDX 4:00:00 PM EDT

9.37

+0.32 (+3.60%)

: $9.88 +0.52 (+5.50%)

Market Cap (Intraday)	834.85M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$27.15 Million
Adjusted EPS	-$1.00

See more estimates

10-Day MA	$9.46
50-Day MA	$10.86
200-Day MA	$14.37

See more pivots

Syndax Pharmaceuticals Inc Stock, NASDAQ:SNDX

730 Third Avenue, floor 9, New York, New York 10017

United States of America

Phone: +1.781.419.1400

Number of Employees: 270

http://www.syndax.com

Description

Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development of cancer therapies. Its product candidates include SNDX-5613 and SNDX-6352. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.